75 related articles for article (PubMed ID: 9731488)
1. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
2. Low susceptibility of Long-Evans Cinnamon rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis and inhibitory effect of urinary copper.
Chone Y; Kinouchi T; Yamada T; Suzuki Y; Kitaura K; Jiao Z; Minami T; Bando Y; Uehara H; Mochizuki M; Ohnishi Y; Izumi K
Jpn J Cancer Res; 2000 Jan; 91(1):16-24. PubMed ID: 10744040
[TBL] [Abstract][Full Text] [Related]
3. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
[TBL] [Abstract][Full Text] [Related]
5. Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Mori S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Fukushima S
Jpn J Cancer Res; 1991 Dec; 82(12):1371-7. PubMed ID: 1778760
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.
Smilowitz HM; Tarmu LJ; Sanders MM; Taylor JA; Choudhary D; Xue C; Dyment NA; Sasso D; Deng X; Hainfeld JF
Int J Nanomedicine; 2017; 12():7937-7946. PubMed ID: 29138560
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Humane Endpoints in a Urinary Bladder Carcinogenesis Study in Rats.
Oliveira M; Nascimento-Gonçalves E; Silva J; Oliveira PA; Ferreira R; Antunes L; Arantes-Rodrigues R; Faustino-Rocha AI
In Vivo; 2017; 31(6):1073-1080. PubMed ID: 29102928
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic credentialing of murine carcinogen-induced urothelial cancer.
Afify H; Ghoneum A; Almousa S; Abdulfattah AY; Warren B; Langsten K; Gonzalez D; Casals R; Bharadwaj M; Kridel S; Said N
Sci Rep; 2021 Nov; 11(1):22085. PubMed ID: 34764423
[TBL] [Abstract][Full Text] [Related]
9. Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model.
Bidinotto LT; Spinardi-Barbisan AL; Rocha NS; Salvadori DM; Barbisan LF
Environ Mol Mutagen; 2006 Oct; 47(8):624-30. PubMed ID: 16878317
[TBL] [Abstract][Full Text] [Related]
10. Lack of promoting effects of alpha-linolenic, linoleic or palmitic acid on urinary bladder carcinogenesis in rats.
Kitano M; Mori S; Chen T; Murai T; Fukushima S
Jpn J Cancer Res; 1995 Jun; 86(6):530-4. PubMed ID: 7622416
[TBL] [Abstract][Full Text] [Related]
11. Urinary Bladder Cancer Induced by N-Butyl-N-(4-Hydroxybutyl)-Nitrosamine.
Zupančič D; Romih R
Methods Mol Biol; 2024; 2773():25-32. PubMed ID: 38236533
[TBL] [Abstract][Full Text] [Related]
12. DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats.
Oliveira PA; Adega F; Palmeira CA; Chaves RM; Colaço AA; Guedes-Pinto H; De la Cruz P LF; Lopes CA
Int J Exp Pathol; 2007 Feb; 88(1):39-46. PubMed ID: 17244337
[TBL] [Abstract][Full Text] [Related]
13.
Wakui S; Takahashi H; Muto T
Toxicol Pathol; 2022 Apr; 50(3):366-380. PubMed ID: 35045775
[TBL] [Abstract][Full Text] [Related]
14. Aging induces changes in cancer formation and microbial content in a murine model of bladder cancer.
Woolbright BL; Xuan H; Ahmed I; Rajendran G; Abbott E; Dennis K; Zhong C; Umar S; Taylor JA
Geroscience; 2024 Jun; 46(3):3361-3375. PubMed ID: 38270807
[TBL] [Abstract][Full Text] [Related]
15. Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
Mohammed A; Miller MS; Lubet RA; Suen CS; Sei S; Shoemaker RH; Juliana MM; Moeinpour FL; Grubbs CJ
Cancer Prev Res (Phila); 2020 Mar; 13(3):273-282. PubMed ID: 31818850
[TBL] [Abstract][Full Text] [Related]
16. Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.
Amponsa VO; Shuman L; Ellis J; Wang E; Walter V; Owens RG; Zaleski M; Warrick JI; Raman JD; DeGraff DJ
Am J Clin Exp Urol; 2019; 7(3):139-152. PubMed ID: 31317053
[TBL] [Abstract][Full Text] [Related]
17. Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
Shah SD; Gillard BM; Wrobel MM; Karasik E; Moser MT; Mastri M; Long MD; Sule N; Brackett CM; Huss WJ; Foster BA
Front Oncol; 2023; 13():1120329. PubMed ID: 36816919
[TBL] [Abstract][Full Text] [Related]
18. Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation.
Xu X; Tian X; Song L; Xie J; Liao JC; Meeks JJ; Wu XR; Gin GE; Wang B; Uchio E; Zi X
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979456
[TBL] [Abstract][Full Text] [Related]
19. Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure.
Hua X; Zou R; Bai X; Yang Y; Lu J; Huang C
BMC Biol; 2023 Aug; 21(1):181. PubMed ID: 37635218
[TBL] [Abstract][Full Text] [Related]
20. SKELETAL MUSCLE SENSITIVITY TO WASTING INDUCED BY UROTHELIAL CARCINOMA.
Esteves M; Duarte M; Oliveira PA; Gil da Costa RM; Monteiro MP; Duarte JA
Exp Oncol; 2023 Jun; 45(1):107-119. PubMed ID: 37417276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
